Comparative Effects of Balance and Inspiratory Muscle Training in Older Adults

March 16, 2026 updated by: Acibadem University

Comparative Effects of Balance and Inspiratory Muscle Training on Balance, Respiratory Muscle Strength, and Physical Performance in Older Adults: A Randomized Comparative Trial

This study aims to investigate and compare the effects of Inspiratory Muscle Training (IMT), balance training, and a combination of both on respiratory muscle strength and balance in older adults. Aging is often associated with a decline in skeletal and respiratory muscle strength, which can increase the risk of falls and impact overall functionality.

Participants aged 60 and over will be randomly assigned to one of three groups:

Respiratory Muscle Training group (30 breaths, twice daily),

Balance Training group (45-50 minute sessions, 3 days a week),

Combined Training group (both IMT and balance exercises).

The intervention will last for 8-weeks. Researchers will evaluate respiratory muscle strength, balance, core endurance, and functional capacity before and after the 8-week program to determine which approach is most effective in improving these parameters in the geriatric population.

Study Overview

Detailed Description

This is a 3-arm randomized comparative trial designed to evaluate the synergistic effects of respiratory and physical interventions in the geriatric population. Physiological changes due to aging, such as reduced inspiratory muscle pressure (MIP) and impaired postural control, are closely linked to increased mortality and fall risk. This study tests the hypothesis that combining IMT with balance training will yield superior outcomes compared to single-mode interventions.

Methodology and Interventions:

Participants will be allocated into three groups using block randomization to ensure gender balance (n=12 per group, total target n=36, accounting for a 20% potential attrition rate):

Group 1 (IMT): Participants will perform 30 breaths twice daily using an IMT device for 8 weeks.

Group 2 (Balance): Participants will attend 45-50 minute supervised balance training sessions, 3 days per week for 8 weeks.

Group 3 (Combined): Participants will perform both the daily IMT protocol and the thrice-weekly balance sessions.

Evaluation Criteria:

Outcomes will be measured at baseline and after the 8-week intervention. Primary outcomes include Maximal Inspiratory Pressure (MIP), Maximal Expiratory Pressure (MEP), Timed Up and Go (TUG) test, Short Physical Performance Battery (SPPB), 6-Minute Walk Test (6MWT), core endurance tests, and single-leg stance balance.

Data from participants who complete at least 70% of the training sessions will be included in the final analysis. The study aims to provide evidence-based recommendations for enhancing functional independence and reducing fall risk in older adults.

Study Type

Interventional

Enrollment (Estimated)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 60 years or older.
  • Mini-Mental State Examination (MMSE) score of 22 or higher.
  • Ability to walk 10 meters independently without human assistance.
  • Ability to read and write.
  • Volunteering to participate and providing written informed consent.

Exclusion Criteria:

  • Current use of sedative or hypnotic medications.
  • Presence of a diagnosed neurological disorder (e.g., history of stroke, Parkinson's disease, Multiple Sclerosis, dementia, or clinical vertigo) that is currently under treatment.
  • Presence of clinically significant cardiovascular or pulmonary complications (e.g., COPD, active lung disease, or uncontrolled hypertension).
  • Severe postural abnormalities that may interfere with the study (e.g., advanced scoliosis or kyphosis).
  • Acute or chronic orthopedic conditions preventing participation in a balance exercise program (e.g., lower extremity fractures or severe joint instability).
  • High risk of sarcopenia, defined as a SARC-F score of 4 or higher.
  • Significant communication or cognitive barriers that prevent following the exercise instructions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Inspiratory Muscle Training
Participants will perform inspiratory muscle training using a threshold device. The protocol consists of 30 breaths, twice daily (60 breaths total per day), for 7 days a week over a period of 8 weeks.
Participants will use a threshold inspiratory muscle trainer device. The training involves performing 30 breaths twice a day (morning and evening), 7 days a week for 8 consecutive weeks. The resistance (intensity) will be adjusted based on the participant's maximal inspiratory pressure (MIP) to ensure progressive training.
Other Names:
  • Threshold IMT
  • Respiratory Muscle Training.
Experimental: Balance Training
Participants will receive a supervised balance training program. The sessions will be held 3 days per week, each lasting 45-50 minutes, for a total duration of 8 weeks.
A structured balance training program conducted under the supervision of a therapist. Sessions last 45-50 minutes, held 3 days per week for 8 weeks. The program includes static and dynamic balance exercises, weight-shifting tasks, and functional movement patterns designed to reduce fall risk.
Experimental: Combined Training Group (IMT + Balance)
Participants will receive both interventions concurrently. This includes the daily IMT protocol (30 breaths, twice daily) and the supervised balance training sessions (45-50 minutes, 3 days per week) for 8 weeks.
Participants will use a threshold inspiratory muscle trainer device. The training involves performing 30 breaths twice a day (morning and evening), 7 days a week for 8 consecutive weeks. The resistance (intensity) will be adjusted based on the participant's maximal inspiratory pressure (MIP) to ensure progressive training.
Other Names:
  • Threshold IMT
  • Respiratory Muscle Training.
A structured balance training program conducted under the supervision of a therapist. Sessions last 45-50 minutes, held 3 days per week for 8 weeks. The program includes static and dynamic balance exercises, weight-shifting tasks, and functional movement patterns designed to reduce fall risk.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal Inspiratory Pressure (MIP)
Time Frame: Baseline and 8 weeks.
MIP will be measured using a digital pressure gauge to evaluate the strength of the inspiratory muscles. The best of three maneuvers will be recorded in cmH2O. Higher values indicate better respiratory muscle strength.
Baseline and 8 weeks.
Maximal Expiratory Pressure (MEP)
Time Frame: Baseline and 8 weeks.
MEP will be measured using a digital pressure gauge to evaluate the strength of the expiratory muscles. The best of three maneuvers will be recorded in cmH2O. Higher values indicate better expiratory muscle strength.
Baseline and 8 weeks.
Timed Up and Go (TUG) Test
Time Frame: Baseline and 8 weeks.
The TUG test measures the time (in seconds) it takes for a participant to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. Lower scores (less time) indicate better functional mobility and balance.
Baseline and 8 weeks.
Respiratory Muscle Endurance (Incremental Threshold Loading Test)
Time Frame: Baseline and 8 weeks.
Respiratory muscle endurance will be assessed using an incremental threshold loading test (ITLT). The test starts with an initial load based on the participant's Maximal Inspiratory Pressure (MIP). The resistance is increased by 20% of the initial MIP value every 2 minutes. Participants are instructed to maintain their breathing pattern against the increasing load until exhaustion or until they can no longer overcome the threshold. The total duration (in seconds) sustained during the test is recorded. Higher values indicate better respiratory muscle endurance.
Baseline and 8 weeks.
Single Leg Stance Test (SLST)
Time Frame: Baseline and 8 weeks.
The participant stands on one leg for as long as possible without support. The time (in seconds) until balance is lost is recorded (up to a maximum of 30 or 60 seconds). Higher values indicate better static balance.
Baseline and 8 weeks.
6-Minute Walk Test (6MWT)
Time Frame: Baseline and 8 weeks.
The 6MWT measures the total distance (in meters) a participant can walk on a flat, hard surface in a period of 6 minutes. It is used to assess submaximal functional exercise capacity.
Baseline and 8 weeks.
Core Muscle Endurance Test
Time Frame: Baseline and 8 weeks.
Core endurance will be assessed using static holding test (McGill's torso endurance test). The duration (in seconds) the participant can maintain the position is recorded. Higher duration indicates better core stability.
Baseline and 8 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery (SPPB)
Time Frame: Baseline and 8 weeks.
SPPB consists of three components: standing balance, gait speed, and chair stand tests. Each component is scored from 0 to 4, with a total score ranging from 0 to 12. Higher scores indicate better physical performance.
Baseline and 8 weeks.
Charlson Comorbidity Index (CCI)
Time Frame: Baseline.
This index categorizes or weights comorbid conditions to predict the 10-year survival for patients. The scores are summed to provide a total score (0 to 37). Higher scores indicate a higher burden of comorbidity and a lower 10-year survival probability.
Baseline.
Mini-Mental State Examination (MMSE)
Time Frame: Baseline.
A 30-point questionnaire used extensively in clinical and research settings to measure cognitive impairment. Scores range from 0 to 30. Higher scores indicate better cognitive function.
Baseline.
Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline.
A rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Total score is 30. Higher scores indicate better cognitive performance.
Baseline.
Tinetti Performance-Oriented Mobility Assessment (POMA)
Time Frame: Baseline and 8 weeks.
A task-oriented test that measures an older adult's gait and balance abilities. The maximum score is 28, with 16 points for balance and 12 for gait. Higher scores indicate better mobility and lower fall risk.
Baseline and 8 weeks.
Handgrip Strength
Time Frame: Baseline and 8 weeks.
Handgrip strength will be measured in kilograms (kg) using a calibrated handheld dynamometer. Participants will perform three trials with their dominant hand, and the maximum value will be recorded. Higher values indicate better upper extremity muscle strength.
Baseline and 8 weeks.
Physical Activity Scale for the Elderly (PASE)
Time Frame: Baseline.
A brief instrument to assess physical activity in older adults. It scores occupational, household, and leisure activities over a one-week period. Higher scores indicate a higher level of physical activity.
Baseline.
Fatigue Impact Scale (FIS)
Time Frame: Baseline.
A self-reported questionnaire that measures the impact of fatigue on daily functioning and quality of life. Higher scores indicate a greater impact of fatigue on the individual's life.
Baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2026

Primary Completion (Estimated)

June 12, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

March 10, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 18, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Geriatric

Clinical Trials on Inspiratory Muscle Training

Subscribe